Related references
Note: Only part of the references are listed.Phase ii/iii study of intraperitoneal chemotherapy after neoadjuvant chemotherapy for ovarian cancer: NCIC CTG OV.21
H. J. Mackay et al.
Current Oncology (2011)
Localized delivery of paclitaxel using elastic liposomes: Formulation development and evaluation
Puneet Utreja et al.
DRUG DELIVERY (2011)
Toxicity studies of cremophor-free paclitaxel solid dispersion formulated by a supercritical antisolvent process
Jae-Hyun Park et al.
ARCHIVES OF PHARMACAL RESEARCH (2009)
Toxic effect of an antitumor drug paclitaxel on morphofunctional characteristics of the liver in rats
L. A. Ermolaeva et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2008)
Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells
Hong Yuan et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
PEGylated Elastic Liposomal Formulation for Lymphatic Targeting of Zidovudine
Subheet Jain et al.
Current Drug Delivery (2008)
Pharmacogenetics of paclitaxel metabolism
Jennifer Spratlin et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles
ZP Zhang et al.
BIOMATERIALS (2006)
The removal of Cremophor® EL from paclitaxel for quantitative analysis by HPLC-UV
JD Perdue et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2006)
Intraperitoneal cisplatin and paclitaxel in ovarian cancer
DK Armstrong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Improvement of paclitaxel therapeutic index by derivatization and association to a cholesterol-rich microemulsion:: in vitro and in vivo studies
DG Rodrigues et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Lyophilized paclitaxel magnetoliposomes as a potential drug delivery system for breast carcinoma via parenteral administration:: In vitro and in vivo studies
JQ Zhang et al.
PHARMACEUTICAL RESEARCH (2005)
Transfersomes - A novel vesicular carrier for enhanced transdermal delivery: Development, characterization, and performance evaluation
S Jain et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2003)
Paclitaxel and its formulations
AK Singla et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2002)
Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation
H Gelderblom et al.
EUROPEAN JOURNAL OF CANCER (2001)
In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy
SC Kim et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Determinants of paclitaxel uptake, accumulation and retention in solid tumors
SH Jang et al.
INVESTIGATIONAL NEW DRUGS (2001)
Tumor physiology and drug resistance
IF Tannock
CANCER AND METASTASIS REVIEWS (2001)
Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin or paclitaxel
A Miglietta et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2000)
Share Paper
